Eventide Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,160,608	Closed	-$20.1M	–	145
2020 Q1	$20.1M	Hold	4,160,608	–	–	0.65%	58
2019 Q4	$44.2M	Hold	4,160,608	–	–	1.25%	32
2019 Q3	$43.3M	Buy	4,160,608 +967,881	+30%	+$10.1M	1.43%	26
2019 Q2	$48.9M	Buy	3,192,727 +1,583,204	+98%	+$24.3M	1.49%	20
2019 Q1	$20.7M	Buy	1,609,523 +523,123	+48%	+$6.72M	0.71%	53
2018 Q4	$10.3M	Hold	1,086,400	–	–	0.46%	68
2018 Q3	$18M	Hold	1,086,400	–	–	0.66%	55
2018 Q2	$17.4M	Hold	1,086,400	–	–	0.72%	52
2018 Q1	$16.6M	Hold	1,086,400	–	–	0.78%	50
2017 Q4	$16.9M	Hold	1,086,400	–	–	0.88%	42
2017 Q3	$12.1M	Hold	1,086,400	–	–	0.68%	54
2017 Q2	$10M	Hold	1,086,400	–	–	0.62%	50
2017 Q1	$9.29M	Buy	1,086,400 +235,000	+28%	+$2.01M	0.62%	52
2016 Q4	$9.11M	Hold	851,400	–	–	0.59%	52
2016 Q3	$9.22M	Hold	851,400	–	–	0.56%	50
2016 Q2	$5.76M	Hold	851,400	–	–	0.35%	69
2016 Q1	$3.97M	Hold	851,400	–	–	0.22%	82
2015 Q4	$5.37M	Buy	851,400 +116,400	+16%	+$734K	0.27%	85
2015 Q3	$6.49M	Buy	735,000 +30,750	+4%	+$272K	0.38%	65
2015 Q2	$8.29M	Buy	704,250 +84,050	+14%	+$989K	0.45%	60
2015 Q1	$8.97M	Buy	620,200 +19,700	+3%	+$285K	0.68%	55
2014 Q4	$10.2M	Buy	600,500 +20,700	+4%	+$353K	1.12%	38
2014 Q3	$7.22M	Buy	579,800 +20,000	+4%	+$249K	1.01%	42
2014 Q2	$8.21M	Buy	559,800 +197,400	+54%	+$2.9M	1.12%	43
2014 Q1	$7.38M	Buy	362,400 +154,300	+74%	+$3.14M	1.15%	43
2013 Q4	$4.08M	Buy	+208,100	New	+$4.08M	1.26%	42